The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a Northern Han Chinese population

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Lv, Yu Dan ^a   Min, Fu Li ^b   Liao, Wei Ping ^b   He, Na ^b   Zeng, Tao ^b   Ma, Di Hui ^a   Shi, Yi Wu ^b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

1502; DNA genotyping; HLA B; Mild maculopapular eruption; Northern Han Chinese

Indexed keywords

HLA B ANTIGEN; OXCARBAZEPINE;

ADULT; AGE; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; FEMALE; GENDER; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; MACULOPAPULAR RASH; MALE; POLYMERASE CHAIN REACTION; POPULATION; RISK FACTOR;

ADULT; ANTICONVULSANTS; ASIAN CONTINENTAL ANCESTRY GROUP; CARBAMAZEPINE; CHINA; DRUG ERUPTIONS; EPILEPSY; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED;

EID: 84879825975     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-75     Document Type: Article

References (24)

1. Rambeck B, Specht U, Wolf P. Pharmacokinetic interactions of the new antiepileptic drugs. Clin Pharmacokinet 1996, 31:309-24. 10.2165/00003088-199631040-00006, 8896946.
2. Chadwick D, Shaw MBM, Foy P, Rawlins MD, Turnbull DM. Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. J Neurol Neurosurg Psychiatry 1984, 47(6):642-4. 10.1136/jnnp.47.6.642, 1027864, 6234378.
3. Kramlinger KG, Phillips KA, Post RM. Rash complicating carbamazepine therapy. J ClinPsychopharmacol 1994, 14(6):408-13.
4. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995, 345(8948):476-9. 10.1016/S0140-6736(95)90581-2, 7710545.
5. Hirsch LJ, Arif H, Nahm EA, Buchsbaum R, Resor SR, Bazil CW. Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology 2008, 71(19):1527-34. 10.1212/01.wnl.0000334295.50403.4c, 18981374.
6. Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia 2007, 48(7):1360-5. 10.1111/j.1528-1167.2007.01109.x, 17484761.
7. Hu FY, Wu XT, An DM, Yan B, Stefan H, Zhou D. Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population. Seizure 2011, 20(2):160-2. 10.1016/j.seizure.2010.11.014, 21169036.
8. Zanni MP, Schnyder B, von Greyerz S, Pichler WJ. Involvement of T cells in drug-induced allergies. Trends Pharmacol Sci 1998, 19(8):308-10. 10.1016/S0165-6147(98)01227-9, 9745357.
9. Hung SI, Chung WH, Jee SH, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genom 2006, 16(4):297-306.
10. Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions. Epilepsia 2007, 48(4):1015-8.
11. Shankarkumar U, Shah KN, Ghosh K. HLA B*1502 allele association with oxcarbamazepine-induced skin reactions in epilepsy patient from India. Epilepsia 2009, 50(7):1837-8. 10.1111/j.1528-1167.2009.02096.x, 20831525.
12. Chen YC, Chu CY, Hsiao CH. Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype. J Eur Acad Dermatol Venereol 2009, 23(6):702-3. 10.1111/j.1468-3083.2008.02988.x, 18785891.
13. Wu XT, Hu FY, An DM, Yan B, Jiang X, Zhou D, et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China. Epilepsy Behav 2010, 19(3):405-8. 10.1016/j.yebeh.2010.08.007, 20833111.
14. He N, Min FL, Shi YW, Guo J, Liu XR, Li BM, et al. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: Incidence, features, risk factors and relation to HLA-B alleles. Seizure 2012, 21(8):614-8. 10.1016/j.seizure.2012.06.014, 22818943.
15. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens Johnson syndrome. Nature 2004, 428(6982):486. 10.1038/428486a, 15057820.
16. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001, 53(3):357-79.
17. Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 2010, 11(3):349-56. 10.2217/pgs.09.162, 20235791.
18. Sharma SR, Sharma N, Yeolekar ME. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report. Indian Dermatol Online J 2011, 2(1):13-15. 10.4103/2229-5178.79861, 3481788, 23130207.
19. Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 2003, 63(3):732-741. 10.1124/mol.63.3.732, 12606784.
20. Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004, 114(5):1209-1215. 10.1016/j.jaci.2004.07.047, 15536433.
21. Park KJ, Kim JR, Joo EY, Seo DW, Hong SB, et al. Drug Interaction and Pharmacokinetic Modeling of Oxcarbazepine in Korean Patients With Epilepsy. Clin Neuropharmacol 2012, 35(1):40-4. 10.1097/WNF.0b013e31824150a5, 22246398.
22. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007, 48(7):1223-44. 10.1111/j.1528-1167.2007.01041.x, 17386054.
23. Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Humara C, Bazil CW, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007, 68(20):1701-9. 10.1212/01.wnl.0000261917.83337.db, 17502552.
24. Klassen BD, Sadler RM. Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug. Epilepsia 2001, 42(3):433-5.